Evaluation of the monoamine uptake site ligand [123I]methyl 3 beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Nuclear Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 8358345
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates.

  1992cited by this paper
• Distribution and kinetics of carbon-11-cocaine in the human body measured with PET.

  1992cited by this paper
• Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.

  1991cited by this paper
• Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter

  1991cited by this paper
• [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain.

  1991cited by this paper
• [125I]RTI-55: a potent ligand for dopamine transporters.

  1991cited by this paper
• Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT.

  1991cited by this paper
• Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA.

  1991cited by this paper
• The next frontier in Parkinson's disease

  1991cited by this paper
• Synthesis, ligand binding, QSAR, and CoMFA study of 3 beta-(p-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters.

  1991cited by this paper
• Cloning of a serotonin transporter affected by antidepressants.

  1991cited by this paper
• The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus

  1991cited by this paper
• Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's‐diseased striatum

  1991cited by this paper
• Cloning and expression of a cocaine-sensitive rat dopamine transporter.

  1991cited by this paper
• Synthesis and receptor binding of N-substituted tropane derivatives. High-affinity ligands for the cocaine receptor.

  1991cited by this paper
• The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.

  1990cited by this paper
• Autoradiographic localization of cocaine binding sites by [3H]CFT ([3H]WIN 35,428) in the monkey brain

  1990cited by this paper
• Rapid Stereoselective Hydrolysis of (+)‐Cocaine in Baboon Plasma Prevents Its Uptake in the Brain: Implications for Behavioral Studies

  1990cited by this paper
• Mapping cocaine binding sites in human and baboon brain in vivo

  1989cited by this paper
• Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine.

  1988cited by this paper
• Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites.

  1988cited by this paper
• [3H]GBR-12935 binding to dopamine uptake sites in the human brain.

  1988cited by this paper
• Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

  1987cited by this paper
• Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease

  1985cited by this paper
• Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.

  1981cited by this paper
• Disposition and metabolism of [3H] cocaine in acutely and chronically treated monkeys.

  1977cited by this paper
• Compounds affecting the central nervous system. 4. 3 Beta-phenyltropane-2-carboxylic esters and analogs.

  1973cited by this paper
• The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons.

  1971cited by this paper

• Radiotracers for imaging of schizophrenia.

  2026cites this paper
• Recent Advances in Synthetic Methods for Radioiodination.

  2020cites this paper
• Bayesian convolutional neural network based MRI brain extraction on nonhuman primates

  2018cites this paper
• Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies

  2017cites this paper
• Circulating tumour necrosis factor is highly correlated with brainstem serotonin transporter availability in humans.

  2016cites this paper
• Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP‐432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects

  2016cites this paper
• A Highly Efficient Copper-Mediated Radioiodination Approach Using Aryl Boronic Acids.

  2016cites this paper
• Venlafaxine alters microvascular perfusion, [¹²³I]-beta-CIT binding and BDI scores in flushing postmenopausal women.

  2014cites this paper
• Iodine-123 labelled reboxetine analogues for imaging of noradrenaline transporter in brain using single photon emission computed tomography

  2013cites this paper
• Iodine‐123 labeled reboxetine analogues for imaging of noradrenaline transporter in brain using single photon emission computed tomography

  2012cites this paper
• Molecular tracers for the PET and SPECT imaging of disease.

  2011cites this paper
• Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination?

  2010cites this paper
• Dopamine and serotonin transporter availability in chronic heroin users: a [¹²³I]β-CIT SPECT imaging study.

  2010cites this paper
• High resolution micro‐SPECT scanning in rats using 125I β‐CIT: Effects of chronic treatment with carbamazepine

  2009cites this paper
• DOPAMINE AND SEROTONIN TRANSPORTER AVAILABILITY DURING ACUTE ALCOHOL WITHDRAWAL: EFFECTS OF COMORBID TOBACCO SMOKING

  2009cites this paper
• Radioiodinated agents for imaging multidrug resistant tumors.

  2009cites this paper
• Radiolabeled 5-iodo-3'-O-(17beta-succinyl-5alpha-androstan-3-one)-2'-deoxyuridine and its 5'-monophosphate for imaging and therapy of androgen receptor-positive cancers: synthesis and biological evaluation.

  2009cites this paper
• Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder

  2009cites this paper
• Synthesis, radiolabeling and baboon SPECT imaging of 2beta-carbomethoxy-3beta-(3'-[(123)I]iodophenyl)tropane ([(123)I]YP256) as a serotonin transporter radiotracer.

  2008cites this paper
• Displacement of Serotonin and Dopamine Transporters by Venlafaxine Extended Release Capsule at Steady State: A [123I]2β-Carbomethoxy-3β-(4-Iodophenyl)-Tropane Single Photon Emission Computed Tomography Imaging Study

  2007cites this paper
• Sex differences in diencephalon serotonin transporter availability in major depression.

  2006cites this paper
• Serotonin transporter and dopamine transporter imaging in the canine brain.

  2006cites this paper
• PET tracers for imaging of the dopaminergic system.

  2006cites this paper
• Serotonin transporter residual availability during long-term antidepressant therapy does not differentiate responder and nonresponder unipolar patients.

  2006cites this paper
• Brain SPECT imaging and whole-body biodistribution with [(123)I]ADAM - a serotonin transporter radiotracer in healthy human subjects.

  2006cites this paper
• Radiohalogens for imaging and therapy.

  2005cites this paper
• PET and SPECT exploration of central monoaminergic transporters for the development of new drugs and treatments in brain disorders.

  2005cites this paper
• Comparison of [123I]ß-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates

  2005cites this paper
• Depletion and restoration of endogenous monoamines affects beta-CIT binding to serotonin but not dopamine transporters in non-human primates.

  2004cites this paper
• Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors.

  2004cites this paper
• Serotonin transporter availability correlates with alcohol intake in non-human primates

  2003cites this paper
• Changes in Human In vivo Serotonin and Dopamine Transporter Availabilities during Chronic Antidepressant Administration

  2003cites this paper
• Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123I]5-I-A-85380 in healthy human subjects

  2002cites this paper
• Synthesis of cyclopentadienyltricarbonyl rhenium phenyltropanes by double ligand transfer: organometallic ligands for the dopamine transporter.

  2002cites this paper
• Relationship between cortisol and serotonin metabolites and transporters in alcoholism [correction of alcolholism].

  2002cites this paper
• Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.

  2002cites this paper
• [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression.

  2001cites this paper
• Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers

  2001cites this paper
• Radiosynthesis of [123I]betaCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain.

  2001cites this paper
• Genotype Influences In Vivo Dopamine Transporter Availability in Human Striatum

  2000cites this paper
• Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT.

  2000cites this paper
• Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.

  2000cites this paper
• 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters.

  2000cites this paper
• SPECT imaging with the D(4) receptor antagonist L-750,667 in nonhuman primate brain.

  2000cites this paper
• [123I]IPCIT and [123I]beta-CIT as SPECT tracers for the dopamine transporter: a comparative analysis in nonhuman primates.

  2000cites this paper
• Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.

  1999cites this paper
• SPECT imaging of pre- and postsynaptic dopaminergic alterations in l-dopa–untreated PD

  1999cites this paper
• Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage

  1999cites this paper
• Effect of treatment with L‐dopa/carbidopa or L‐selegiline on striatal dopamine transporter SPECT imaging with [123I]β‐CIT

  1999cites this paper
• Reduced central serotonin transporters in alcoholism.

  1998cites this paper
• Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

  1998cites this paper
• Dopamine transporter imaging with fluorine-18-FPCIT and PET.

  1998cites this paper
• In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates.

  1998cites this paper
• Tourette's syndrome

  1998cites this paper
• Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.

  1998cites this paper
• Fluorine-18-FPCT: a PET radiotracer for imaging dopamine transporters.

  1997cites this paper
• Synthesis and radioiodination of a stannyl oligodeoxyribonucleotide.

  1997cites this paper
• SPECT-Evaluation of the Monoamine Uptake Site Ligand [123I](1R)- 2-Beta-Carbomethoxy-3-Beta-(4-iodophenyl)-Tropane ([123I]Beta- CIT) in Untreated Patients with Suspicion of Parkinson Disease

  1997cites this paper
• Preclinical evaluation of [123I]R93274 as a SPECT radiotracer for imaging 5-HT2A receptors.

  1997cites this paper
• Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.

  1997cites this paper
• A new iodinated tropane derivative (β‐CDIT) for in vivo dopamine transporter exploration: Comparison with β‐CIT

  1997cites this paper
• Analysis of the metabolites of [I‐123]β‐CIT in plasma of human and nonhuman primates

  1997cites this paper
• Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.

  1996cites this paper
• Effects of cocaine on [11C]norepinephrine and [11C]β-CIT uptake in the primate peripheral organs measured by PET

  1996cites this paper
• Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter.

  1996cites this paper
• Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3 beta-(4-[125I]iodophenyl) tropan-2 beta-carboxylic acid isopropyl ester ([125I]RTI-121).

  1996cites this paper
• [123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

  1996cites this paper
• N-substituted analogs of 2 beta-carbomethoxy-3 beta- (4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain.

  1996cites this paper
• Characterization of the dopamine transporter in nonhuman primate brain: homogenate binding, whole body imaging, and ex vivo autoradiography using [125I] and [123I]IPCIT.

  1995cites this paper
• Parkinson's disease: epidemiology, (differential) diagnosis, therapy, relation to dementia.

  1995cites this paper
• No-carrier-added meta-[123I]iodobenzylguanidine: synthesis and preliminary evaluation.

  1995cites this paper
• Simplified multidose preparation of iodine-123-beta-CIT: a marker for dopamine transporters.

  1995cites this paper
• Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.

  1995cites this paper
• Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease

  1995cites this paper
• Regional brain uptake and pharmacokinetics of [123I]N-omega-fluoroalkyl-2 beta-carboxy-3 beta-(4-iodophenyl)nortropane esters in baboons.

  1995cites this paper
• Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication.

  1995cites this paper
• N.c.a. radiosynthesis of [123,124I]beta-CIT, plasma analysis and pharmacokinetic studies with SPECT and PET.

  1995cites this paper
• The metabolite pattern of [123I]beta-CIT determined with a gradient HPLC method.

  1995cites this paper
• Lipophilic metabolite of [123I]β‐CIT in human plasma may obstruct quantitation of the dopamine transporter

  1995cites this paper
• Novel radioligands for the dopamine transporter demonstrate the presence of intrastriatal nigral grafts in the MPTP-treated monkey: correlation with improved behavioral function.

  1994cites this paper
• Pharmacokinetics of the three radioiodinated dopamine D2 receptor ligands [123I]IBF, [123I]epidepride and [123I]2'-ISP in nonhuman primates.

  1994cites this paper
• Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.

  1994cites this paper
• Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects

  1994cites this paper
• N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters.

  1994cites this paper
• Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil.

  1994cites this paper
• Formation of 1-[123I]iodobutane in labeling [123I]iomazenil by iododestannylation: implications for the reaction mechanism.

  1994cites this paper
• Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.

  1993cites this paper
• Initial experience with single-photon emission tomography using iodine-123-labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane in human brain.

  1993cites this paper